Stay updated with breaking news from Keystone Symposium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Ladies and gentlemen, thank you for joining us today. Welcome to Compugen's First Quarter 2024 Results Conference Call. At this time, all participants are in a listen-only mode.
FOR IMMEDIATE RELEASE: Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy ...
VALBIOTIS SA Valbiotis publishes its financial report for the first half of 2023 and confirms its strategic roadmap 28-Sep-2023 / 17:40 CET/CEST Dissemination of a French...
- Program Updates Planned for Azer-cel and PBCAR19B in May 2023 - Presented data on PBGENE-HBV program at Global Hepatitis Summit 2023; PBGENE-DMD program data update upcoming at ASGCT... | May 9, 2023
SINGAPORE, Dec. 21, 2022 /PRNewswire/ -- Nuevocor, a pre-clinical stage cardiac gene therapy company, announced today that it will be presenting at the Biotech Showcase during JPM week, taking place in San Francisco, CA, USA from January 9 to 11, 2023. Nuevocor will also be giving an oral presentation on new pre-clinical data for its LMNA cardiac gene therapy...